World's Best Scientists 2026 revealed!
Koshi Mimori

Koshi Mimori

D-Index & Metrics

Medicine

D-Index
98
Citations
32982
World Ranking
8964
National Ranking
237

Overview

Koshi Mimori is affiliated with Kyushu University in Japan, where their research predominantly spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work includes significant contributions to subfields such as Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine, and Surgery.

The scientist's research topics mainly focus on Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies, Cancer-related molecular mechanisms research, RNA modifications and cancer, and Cancer-related gene regulation.

Recent publications by Koshi Mimori include:

  • The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling, 2020, Gastroenterology
  • YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma, 2020, Science Advances
  • Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer, 2023, Cell Reports
  • Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer, 2020, Cancer Science
  • The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer, 2021, Cancer Science

Koshi Mimori collaborates frequently with several researchers, including:

  • Takaaki Masuda
  • Taro Tobo
  • Yusuke Yonemura
  • Masaki Mori
  • Akihiro Kitagawa

Publications appear frequently in specialized venues such as:

  • Cancer Science
  • Cancer Research
  • Annals of Gastroenterological Surgery
  • Anticancer Research
  • Cancer Genomics & Proteomics

Best Publications

  • Long Noncoding RNA HOTAIR Regulates Polycomb-Dependent Chromatin Modification and Is Associated with Poor Prognosis in Colorectal Cancers

    Ryunosuke Kogo;Teppei Shimamura;Koshi Mimori;Kohichi Kawahara

  • Epithelial–mesenchymal transition in cancer development and its clinical significance

    Masaaki Iwatsuki;Koshi Mimori;Takehiko Yokobori;Hideshi Ishi

  • Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

    Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Hiroaki Nagano;Naotsugu Haraguchi

  • Characterization of a side population of cancer cells from human gastrointestinal system

    Naotsugu Haraguchi;Tohru Utsunomiya;Hiroshi Inoue;Fumiaki Tanaka

  • CD13 is a therapeutic target in human liver cancer stem cells

    Naotsugu Haraguchi;Hideshi Ishii;Hideshi Ishii;Koshi Mimori;Fumiaki Tanaka

  • CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

    Hui Ling;Riccardo Spizzo;Yaser Atlasi;Milena Nicoloso

  • Age-related remodelling of oesophageal epithelia by mutated cancer drivers

    Akira Yokoyama;Nobuyuki Kakiuchi;Tetsuichi Yoshizato;Yasuhito Nannya

  • Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction

    Masaki Mori;Koshi Mimori;Hiroshi Inoue;Graham F. Barnard

  • Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

    T Matsumura;K Sugimachi;H Iinuma;Y Takahashi

  • Over- and under-expressed microRNAs in human colorectal cancer

    Kazuo Motoyama;Hiroshi Inoue;Yasushi Takatsuno;Yasushi Takatsuno;Fumiaki Tanaka

  • p27 expression and gastric carcinoma.

    Masaki Mori;Koshi Mimori;Takeshi Shiraishi;Shinji Tanaka

  • Defined factors induce reprogramming of gastrointestinal cancer cells

    Norikatsu Miyoshi;Hideshi Ishii;Hideshi Ishii;Ken Ichi Nagai;Hiromitsu Hoshino

  • Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers

    Y Takahashi;G Sawada;J Kurashige;R Uchi

  • Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer

    Hisae Iinuma;Toshiaki Watanabe;Koshi Mimori;Miki Adachi

  • Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population

    Genta Sawada;Genta Sawada;Atsushi Niida;Ryutaro Uchi;Hidenari Hirata

  • MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab

    Naohiro Nishida;Koshi Mimori;Muller Fabbri;Takehiko Yokobori

  • Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease

    Masaki Mori;Koshi Mimori;Hiroaki Ueo;Nobuya Karimine

  • CD133+CD44+ population efficiently enriches colon cancer initiating cells

    Naotsugu Haraguchi;Masahisa Ohkuma;Hiroyuki Sakashita;Shinji Matsuzaki

  • Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma

    Masahisa Ishibashi;Ryunosuke Kogo;Kohei Shibata;Genta Sawada

  • Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis

    Takehiko Yokobori;Hisae Iinuma;Teppei Shimamura;Seiya Imoto

Frequent Co-Authors

Masaki Mori
Masaki Mori Kyushu University
Hidetoshi Eguchi
Hidetoshi Eguchi Osaka University
Yuichiro Doki
Yuichiro Doki Osaka University
Yoshihiko Maehara
Yoshihiko Maehara Kyushu University
Satoru Miyano
Satoru Miyano Tokyo Medical and Dental University
Hirofumi Yamamoto
Hirofumi Yamamoto Osaka University
Akira Suzuki
Akira Suzuki Kobe University
Hideo Baba
Hideo Baba Kumamoto University
Shoji Natsugoe
Shoji Natsugoe Kagoshima University
Mitsuru Sasako
Mitsuru Sasako Hyogo College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers many career pathways beyond a traditional MD. Students interested in healthcare leadership can consider the cheapest online mha programs, which provide a cost-effective route to roles in medical management and administration.

For those aiming to advance clinical skills, the best online dnp programs make earning a Doctor of Nursing Practice more accessible, especially for working nurses seeking to move into advanced practice or leadership positions.

Pharmacy is another growing field. With an online pharmd, students can qualify for clinical pharmacy roles without disrupting their current professional obligations.

Finally, the digital transformation of healthcare has made bachelor of health information management online programs increasingly important. Graduates pursue careers in managing patient data, healthcare analytics, and health IT systems.

Exploring these diverse online programs can open doors to rewarding careers in healthcare beyond traditional medicine.

Best Scientists Citing Koshi Mimori

Trending Scientists